Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,OR[95%CI],P_value
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",ADGRD1,Adhesion G-protein coupled receptor D1,11660,258,5.27 [3.99-6.95],9.391488650108374e-32
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",AGRN,Agrin,13821,296,2.43 [1.83-3.23],6.806181649534724e-10
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",AMOT,Angiomotin,11660,258,2.42 [1.89-3.09],1.5595090908192645e-12
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",ANGPTL4,Angiopoietin-related protein 4,13800,296,1.90 [1.52-2.37],1.793071179713056e-08
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",APOF,Apolipoprotein F,11933,265,0.33 [0.22-0.48],1.2894682568501762e-08
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",ASAH2,Neutral ceramidase,13666,284,2.24 [1.77-2.83],1.2041682122832414e-11
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",BPIFB2,BPI fold-containing family B member 2,11912,260,1.61 [1.38-1.88],1.4817894857746691e-09
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CA14,Carbonic anhydrase 14,13885,295,0.43 [0.31-0.58],3.1071800135975064e-08
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CCER2,Coiled-coil domain-containing glutamate-rich protein 2,11605,258,1.63 [1.37-1.95],7.927987783317019e-08
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CCN3,CCN family member 3,13906,295,2.24 [1.70-2.96],1.2612281471213112e-08
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CDCP1,CUB domain-containing protein 1,13666,284,1.84 [1.51-2.24],1.6878814603964475e-09
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,11660,258,9.12 [6.43-12.93],2.9156878096734625e-35
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",COL5A1,Collagen alpha-1(V) chain,11660,258,2.25 [1.76-2.89],1.393192576720484e-10
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CRLF1,Cytokine receptor-like factor 1,13821,296,0.32 [0.22-0.46],1.3470142803521423e-09
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CSF1,Macrophage colony-stimulating factor 1,13821,296,2.78 [1.94-3.98],2.7939449617757848e-08
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CSPG4,Chondroitin sulfate proteoglycan 4,11911,261,3.44 [2.42-4.88],5.126807823186505e-12
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CTHRC1,Collagen triple helix repeat-containing protein 1,11911,261,3.16 [2.12-4.70],1.4209062907013433e-08
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CTSO,Cathepsin O,13917,294,2.77 [2.04-3.75],5.424073137197821e-11
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CTSZ,Cathepsin Z,13713,294,3.28 [2.39-4.48],1.2686612053322858e-13
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",DCTPP1,dCTP pyrophosphatase 1,13762,293,2.49 [1.82-3.41],1.2198571598874662e-08
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",DPP4,Dipeptidyl peptidase 4,13448,290,3.16 [2.26-4.42],1.5083455717821715e-11
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",DPT,Dermatopontin,13923,295,3.99 [2.62-6.07],1.25144282233404e-10
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",EDA2R,Tumor necrosis factor receptor superfamily member 27,13885,295,2.86 [2.17-3.77],6.87497164659738e-14
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",ERBB2,Receptor tyrosine-protein kinase erbB-2,13793,295,4.46 [2.96-6.72],9.403193400845702e-13
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",FABP4,"Fatty acid-binding protein, adipocyte",13923,295,1.87 [1.53-2.29],1.110519008837615e-09
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",FCER2,Low affinity immunoglobulin epsilon Fc receptor,13760,292,2.01 [1.61-2.51],5.436918929501886e-10
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",FCRL2,Fc receptor-like protein 2,13854,294,0.49 [0.39-0.62],3.0829558405482606e-09
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",FLT3LG,Fms-related tyrosine kinase 3 ligand,13917,294,6.45 [4.82-8.65],9.518379680065192e-36
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,13890,294,2.35 [1.87-2.94],9.844038275704133e-14
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",GAS6,Growth arrest-specific protein 6,13823,294,2.93 [1.98-4.34],7.145822499555796e-08
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",GDF15,Growth/differentiation factor 15,13923,295,1.62 [1.36-1.93],6.451744870645808e-08
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",GFRA1,GDNF family receptor alpha-1,13864,295,2.94 [2.06-4.20],3.0631976033877504e-09
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",GPNMB,Transmembrane glycoprotein NMB,13393,283,2.95 [2.02-4.29],1.6439613089467146e-08
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",GUSB,Beta-glucuronidase,13807,293,1.73 [1.47-2.03],3.7337911878583477e-11
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,13885,295,1.97 [1.54-2.53],9.261453168099202e-08
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",IGSF3,Immunoglobulin superfamily member 3,13694,294,1.92 [1.55-2.38],2.157552312566235e-09
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",LGALS9,Galectin-9,13750,296,2.35 [1.74-3.16],2.0475680519159826e-08
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",LMNB2,Lamin-B2,11897,262,2.93 [2.11-4.08],1.458748428429448e-10
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",LRP1,Prolow-density lipoprotein receptor-related protein 1,13694,294,2.83 [1.99-4.02],7.210783787368146e-09
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",LTBP2,Latent-transforming growth factor beta-binding protein 2,13923,295,2.87 [2.10-3.93],3.3516910501329397e-11
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",LYZL2,Lysozyme-like protein 2,11503,254,2.37 [1.92-2.92],6.327856090808067e-16
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",MAMDC2,MAM domain-containing protein 2,11932,261,3.28 [2.38-4.53],4.761089613669232e-13
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",MEGF9,Multiple epidermal growth factor-like domains protein 9,13873,295,3.49 [2.25-5.41],2.2446520625936786e-08
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",MEPE,Matrix extracellular phosphoglycoprotein,13759,296,0.40 [0.29-0.56],5.799886996397765e-08
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",MFAP5,Microfibrillar-associated protein 5,13923,295,0.46 [0.36-0.58],1.21484691584866e-10
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",MRC1,Macrophage mannose receptor 1,11933,265,2.92 [1.97-4.31],7.543363528665818e-08
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",NEFL,Neurofilament light polypeptide,13369,285,1.99 [1.59-2.49],2.345514562037813e-09
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",NFASC,Neurofascin,13917,294,3.37 [2.35-4.84],4.700483483979195e-11
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",NRP2,Neuropilin-2,13760,292,3.04 [2.23-4.12],1.15054410362255e-12
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",OMD,Osteomodulin,13821,296,2.08 [1.62-2.66],9.483316714886888e-09
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",PAEP,Glycodelin,13666,284,0.76 [0.70-0.84],5.638589994425509e-09
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",PCDH17,Protocadherin-17,13762,293,2.29 [1.72-3.04],1.1684523519960884e-08
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",PGLYRP2,N-acetylmuramoyl-L-alanine amidase,11785,263,3.22 [2.19-4.74],2.599933135370383e-09
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",PRL,Prolactin,13890,294,0.64 [0.55-0.74],6.800226890286214e-10
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,11932,261,2.83 [2.00-4.02],5.163584999781567e-09
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",RBFOX3,RNA binding protein fox-1 homolog 3,11913,260,2.04 [1.62-2.58],1.873126628240674e-09
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",RET,Proto-oncogene tyrosine-protein kinase receptor Ret,13694,294,1.95 [1.53-2.48],5.2398398978385653e-08
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",ROBO1,Roundabout homolog 1,13784,296,3.66 [2.47-5.43],1.0811370397466088e-10
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",ROBO2,Roundabout homolog 2,13890,294,4.60 [2.98-7.10],6.033478181144713e-12
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",SDC1,Syndecan-1,13762,293,1.91 [1.56-2.33],2.36051105934977e-10
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",SERPINA6,Corticosteroid-binding globulin,11944,264,9.38 [5.90-14.91],3.163818951235683e-21
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",SKAP1,Src kinase-associated phosphoprotein 1,13637,284,0.62 [0.53-0.72],9.822923855658363e-10
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",SPON1,Spondin-1,13784,296,2.82 [2.11-3.76],1.849770014044338e-12
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",SPP1,Osteopontin,13894,294,2.29 [1.85-2.85],6.183912070654227e-14
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",STC2,Stanniocalcin-2,13737,292,0.33 [0.25-0.45],2.874309783197085e-13
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",TCL1A,T-cell leukemia/lymphoma protein 1A,13639,284,1.50 [1.35-1.68],1.9875130692542999e-13
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",TFF2,Trefoil factor 2,13800,296,1.58 [1.35-1.85],1.5857904287218468e-08
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,13784,296,0.28 [0.19-0.39],1.6230019782704673e-12
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,13893,295,3.69 [2.69-5.07],5.482796080434183e-16
